Experts disagree on whether DPIs or low emissions pMDIs are the way forward for effective, environmentally friendly inhalers. Credit: Pixel-Shot/Shutterstock In a bid to improve
Minister for Science Lord Vallance said Labour seek closer ties with commercial clinical industry to ignite innovation. Credit: Frankie Fattorini/GlobalData Lord Patrick Vallance has emphasised
The Danish companies aim to jointly develop a GLP-1RA administered once a month. Credit: Kittyfly / Shutterstock Novo Nordisk and Ascendis Pharma have agreed to
: SP-624 may treat depression in women by modulating the distinct female genetic profile. Credit: Prathankarnpap/Shutterstock Arrivo BioVentures’ SIRT6 activator SP-624 has been found to
Pfizer CEO Dr Albert Bourla presided over an exceptional Q3 amid financial decline and pressure from investor Starboard Value. Credit: Ververidis Vasilis / Shutterstock. Pfizer
Self-amplifying vaccines promise extended efficacy with lower doses than their mRNA predecessors, but approvals have been slow to materialize. Credit: Javier Zayas Photography/ Getty Images
Genevant LNP technology will provide a vehicle for Editas’ CRISPR/Cas12a gene therapy. Credit: ART-ur / Shutterstock. Editas Medicine and Genevant Sciences will collaborate to develop
Hanmi will advance its cancer assets through MEDiC’s MCAT platform in return for upfront payments, along with $5m in funding. Credit: sonnim/ Shutterstock Leading Korean
The EPO ruling affirms bit.bio’s European patent for opti-ox, its proprietary stem cell engineering technology. Credit: Yavdat/ Shutterstock bit.bio has successfully defended the European patent
Anima’s Lighting platform uses machine learning to identify therapeutically relevant mRNAs. Credit: Chaosamran_Studio/ Shutterstock Anima Biotech is utilising machine learning (ML) to investigate the role